These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 36414386)

  • 1. How to interpret cardiac biomarkers in children?
    McGinn C; Waterfield T; McKeeman G; Morrison L; Callaghan S; Watson C; Casey FA
    Arch Dis Child Educ Pract Ed; 2023 Aug; 108(4):265-270. PubMed ID: 36414386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paediatric heart failure - understanding the pathophysiology and the current role of cardiac biomarkers in clinical practice.
    McGinn C; Casey FA; Watson C; Morrison L
    Cardiol Young; 2023 Apr; 33(4):503-513. PubMed ID: 36951045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac biomarkers in children with congenital heart disease.
    Sugimoto M; Kuwata S; Kurishima C; Kim JH; Iwamoto Y; Senzaki H
    World J Pediatr; 2015 Nov; 11(4):309-15. PubMed ID: 26454435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
    Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
    Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trending Cardiac Biomarkers During Pregnancy in Women With Cardiovascular Disease.
    Chang SA; Khakh P; Janzen M; Lee T; Kiess M; Rychel V; Grewal J
    Circ Heart Fail; 2022 Aug; 15(8):e009018. PubMed ID: 35904022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac injury biomarkers in paediatric age: Are we there yet?
    Neves AL; Henriques-Coelho T; Leite-Moreira A; Areias JC
    Heart Fail Rev; 2016 Nov; 21(6):771-781. PubMed ID: 27255332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normative Values of High-Sensitivity Cardiac Troponin T and N-Terminal pro-B-Type Natriuretic Peptide in Children and Adolescents: A Study from the CALIPER Cohort.
    Lam E; Higgins V; Zhang L; Chan MK; Bohn MK; Trajcevski K; Liu P; Adeli K; Nathan PC
    J Appl Lab Med; 2021 Mar; 6(2):344-353. PubMed ID: 32995884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study).
    Puleo CW; Ayers CR; Garg S; Neeland IJ; Lewis AA; Pandey A; Drazner MH; de Lemos JA
    Biomark Med; 2021 Nov; 15(16):1487-1498. PubMed ID: 34663078
    [No Abstract]   [Full Text] [Related]  

  • 9. Usefulness of N-terminal pro-B-type natriuretic peptide (NT-ProBNP) as a marker for cardiotoxicity and comparison with echocardiography in paediatric carbon monoxide poisoning.
    Turan C; Dogan E; Yurtseven A; Saz EU
    Cardiol Young; 2020 Aug; 30(8):1103-1108. PubMed ID: 32571446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.
    Pandey A; Patel KV; Vongpatanasin W; Ayers C; Berry JD; Mentz RJ; Blaha MJ; McEvoy JW; Muntner P; Vaduganathan M; Correa A; Butler J; Shimbo D; Nambi V; deFilippi C; Seliger SL; Ballantyne CM; Selvin E; de Lemos JA; Joshi PH
    Circulation; 2019 Dec; 140(25):2076-2088. PubMed ID: 31707797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
    Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
    Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients.
    Eriguchi M; Tsuruya K; Lopes M; Bieber B; McCullough K; Pecoits-Filho R; Robinson B; Pisoni R; Kanda E; Iseki K; Hirakata H
    ESC Heart Fail; 2022 Apr; 9(2):1138-1151. PubMed ID: 35026869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy.
    Weinmann K; Werner J; Koenig W; Rottbauer W; Walcher D; Keßler M
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31731547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure.
    Konev AA; Kharitonov AV; Rozov FN; Altshuler EP; Serebryanaya DV; Lassus J; Harjola VP; Katrukha AG; Postnikov AB
    ESC Heart Fail; 2020 Apr; 7(2):434-444. PubMed ID: 31967738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT-ProBNP and high-sensitivity troponin T as screening tests for subclinical chronic heart failure in a general population.
    Averina M; Stylidis M; Brox J; Schirmer H
    ESC Heart Fail; 2022 Jun; 9(3):1954-1962. PubMed ID: 35322586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
    Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
    Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.
    Cantinotti M; Law Y; Vittorini S; Crocetti M; Marco M; Murzi B; Clerico A
    Heart Fail Rev; 2014 Nov; 19(6):727-42. PubMed ID: 24473828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [NT-proBNP as a diagnostic marker in dogs with dyspnea and in asymptomatic dogs with heart murmur].
    Haßdenteufel E; Kresken JG; Henrich E; Hildebrandt N; Schneider C; Stosic A; Schneider M
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(3):171-9. PubMed ID: 22688794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure biomarker levels correlate with invasive haemodynamics in pulmonary valve replacement.
    Zegelbone PM; Ringel RE; Coulson JD; Nies MK; Stabler ME; Brown JR; Everett AD
    Cardiol Young; 2020 Jan; 30(1):50-54. PubMed ID: 31771681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is N-terminal pro-brain type natriuretic peptide a useful marker in newborns with heart defects?
    Tarkowska A; Furmaga-Jabłońska W
    Adv Clin Exp Med; 2021 Sep; 30(9):905-912. PubMed ID: 34327879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.